Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (3,558)

Search Parameters:
Keywords = MAYO

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
27 pages, 9267 KB  
Article
Modeling and Box–Behnken Design Optimization for the Efficient Removal of Ibuprofen via Heterogeneous Fenton-like Reactions Using a Fe3O4/HNTs as a Catalyst
by Erick A. García-García, Adolfo E. Obaya-Valdivia, Jaime Jiménez-Becerril, Julio C. Morales-Mejía, José A. Chávez-Carvayar and Yolanda M. Vargas-Rodríguez
Processes 2026, 14(10), 1609; https://doi.org/10.3390/pr14101609 - 15 May 2026
Abstract
A Fe3O4/HNTs composite was synthesized, characterized by SEM, TEM, XPS, adsorption–desorption N2, XRD, FTIR, VSM and Zeta potential, and was used for an ibuprofen adsorption and Fenton oxidation study. The response surface methodology (RSM) and Box–Behnken experimental [...] Read more.
A Fe3O4/HNTs composite was synthesized, characterized by SEM, TEM, XPS, adsorption–desorption N2, XRD, FTIR, VSM and Zeta potential, and was used for an ibuprofen adsorption and Fenton oxidation study. The response surface methodology (RSM) and Box–Behnken experimental designs were employed. The effects of pH, contact time, ibuprofen concentration, and Fe3O4/HNTs dosage on ibuprofen adsorption were evaluated. Additionally, adsorption isotherms and a kinetic study were performed. The effects of pH, H2O2 concentration, and Fe3O4/HNTs dosage for IBU removal were also studied. The results of ibuprofen adsorption on Fe3O4/HNTs indicate that adsorption was favored at acidic pH. The adsorption followed pseudo-second-order kinetics and a Freundlich isotherm. Under mild conditions (pH 7, 298.15 K) with a Fe3O4/HNTs dosage of 1.5 g L−1 and 0.5 M H2O2, the heterogeneous Fenton-like reaction achieved 99% ibuprofen removal and 60% mineralization. The Fe3O4/HNTs catalyst demonstrated high efficiency for aqueous ibuprofen removal under environmentally mild pH and temperature conditions, and it was easily recoverable and reusable. Full article
Show Figures

Figure 1

23 pages, 9606 KB  
Article
Hyaluronan Regulates Vascular Smooth Muscle Cell Osteogenic Differentiation and Vascular Calcification
by Shrea Roy, Jamie Kane, Irina Grigorieva, Dylan Roche-Dugmore, Sacha Moore, Robert Steadman, Anne-Catherine Raby, Lily Jakulj, Leon Schurgers, Esther Lutgens, Etto C. Eringa, Marc Vervloet, Donald Fraser and Soma Meran
Biomolecules 2026, 16(5), 729; https://doi.org/10.3390/biom16050729 (registering DOI) - 15 May 2026
Abstract
Vascular calcification is a strong predictor of cardiovascular mortality and lacks effective treatment. The transformation of vascular smooth muscle cells (VSMCs) into osteoblast-like phenotypes is a key driver of calcification. This study identifies a regulatory role for Hyaluronan (HA) in VSMC osteogenic differentiation [...] Read more.
Vascular calcification is a strong predictor of cardiovascular mortality and lacks effective treatment. The transformation of vascular smooth muscle cells (VSMCs) into osteoblast-like phenotypes is a key driver of calcification. This study identifies a regulatory role for Hyaluronan (HA) in VSMC osteogenic differentiation and arterial calcification. Human aortic VSMCs stimulated with high phosphate and/or pro-inflammatory cytokines (IL6 and TGF-β1) exhibited increased RUNX2, alkaline phosphatase and osteopontin expression, along with reduced contractility and elevated calcium deposition. This corresponded with reduced HA deposition and downregulation of HA synthase enzymes (HAS1, HAS2), Hyaluronidase enzymes (Hyal1), and HA binding proteins (CD44, TSG-6), whilst HAS3 and versican were upregulated. Comparable alterations in HA and protein expression were observed in an in vivo model of arterial calcification using vitamin K-deficient warfarin-fed mice. Pharmacological inhibition of HA synthesis, enzyme-mediated HA degradation and siRNA/plasmid modulation of HAS isoenzymes demonstrated a possible functional link between HA regulation and VSMC osteogenic differentiation. This study establishes HA and its associated binding proteins as key regulators of arterial calcification, highlighting a novel pathway for potential therapeutic intervention. Full article
(This article belongs to the Special Issue Function and Regulation of Hyaluronan and Hyalectins in Disease)
14 pages, 1601 KB  
Review
Cardiac Implications of Preeclampsia: A Review
by Beani J. Forst, Linda R. Chambliss and David S. Majdalany
J. Pers. Med. 2026, 16(5), 265; https://doi.org/10.3390/jpm16050265 - 15 May 2026
Abstract
Preeclampsia (PE) is a multifactorial hypertensive disorder of pregnancy that significantly increases both short- and long-term cardiovascular risk for affected women. PE and cardiovascular disease (CVD) share common risk factors, including endothelial dysfunction, obesity, insulin resistance, and dyslipidemia. Women with a history of [...] Read more.
Preeclampsia (PE) is a multifactorial hypertensive disorder of pregnancy that significantly increases both short- and long-term cardiovascular risk for affected women. PE and cardiovascular disease (CVD) share common risk factors, including endothelial dysfunction, obesity, insulin resistance, and dyslipidemia. Women with a history of PE face a markedly elevated risk of chronic hypertension, heart failure, and adverse cardiac remodeling, with evidence suggestive of persistent vascular and myocardial changes after pregnancy. The complex pathophysiology of PE is multifactorial and is thought to involve a combination of abnormal placentation, immune dysregulation, and anti-angiogenic factors, which may induce permanent cardiovascular alterations. Genetic predispositions may further link PE with cardiomyopathies and peripartum cardiomyopathy. However, despite these well-established risks, standardized long-term surveillance and management strategies for women with prior PE remain lacking. Early identification and targeted intervention in women with a history of PE represent critical opportunities to mitigate future cardiovascular morbidity and mortality. This review highlights the urgent need for comprehensive, evidence-based strategies that incorporate personalized follow-up and risk stratification to improve cardiovascular outcomes in this high-risk population. Full article
(This article belongs to the Section Personalized Medical Care)
Show Figures

Figure 1

15 pages, 846 KB  
Review
Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation
by Panuch Eiamprapaporn, Cindy Venegas Mata, Raj Nandani, Thiti Susiriwatananont, Keith L. Knutson and Saranya Chumsri
Cancers 2026, 18(10), 1588; https://doi.org/10.3390/cancers18101588 - 13 May 2026
Viewed by 90
Abstract
Triple-negative breast cancer (TNBC) represents a biologically aggressive subtype with limited therapeutic targets; however, tumor-infiltrating lymphocytes (TILs) have emerged as the most robust immune biomarker with compelling prognostic and predictive significance. This comprehensive review synthesizes current evidence on TIL assessment methodology; the immunobiological [...] Read more.
Triple-negative breast cancer (TNBC) represents a biologically aggressive subtype with limited therapeutic targets; however, tumor-infiltrating lymphocytes (TILs) have emerged as the most robust immune biomarker with compelling prognostic and predictive significance. This comprehensive review synthesizes current evidence on TIL assessment methodology; the immunobiological landscape of TNBC, including regulatory T cell populations and PD-L1 correlations; gene expression underpinnings of the tumor immune microenvironment; and systematic evidence from meta-analyses and clinical trials. Meta-analytic estimates demonstrate that high TIL levels are associated with improved overall survival (HR 0.58, 95% CI 0.48–0.71) and disease-free survival (HR 0.66, 95% CI 0.57–0.76), with each 10% TIL increment conferring incremental benefit. High TILs predict superior pathologic complete response to neoadjuvant chemotherapy (OR 2.14, 95% CI 1.43–3.19), with lymphocyte-predominant breast cancer achieving pCR rates exceeding 80% with pembrolizumab-based chemoimmunotherapy. Future directions include prospective TIL-guided treatment trials, artificial intelligence-enabled standardization, and emerging adoptive TIL cellular therapies for metastatic disease. Full article
Show Figures

Figure 1

15 pages, 1852 KB  
Article
Extracellular Vesicle-Mediated Delivery of Curcumin Suppresses Tumor Progression in Murine Oral Squamous Cell Carcinoma
by Nils Ludwig, Carolin Feldmann, Silvia Spoerl and Saigopalakrishna S. Yerneni
Cancers 2026, 18(10), 1586; https://doi.org/10.3390/cancers18101586 - 13 May 2026
Viewed by 85
Abstract
Rationale: Oral squamous cell carcinoma (OSCC) carries a poor prognosis despite advances in multimodal therapy. Nanomedicine represents a compelling strategy to enhance targeted drug delivery and improve therapeutic outcomes. Here, we investigated sEV-mediated delivery of curcumin as a novel therapeutic approach for [...] Read more.
Rationale: Oral squamous cell carcinoma (OSCC) carries a poor prognosis despite advances in multimodal therapy. Nanomedicine represents a compelling strategy to enhance targeted drug delivery and improve therapeutic outcomes. Here, we investigated sEV-mediated delivery of curcumin as a novel therapeutic approach for OSCC. Methods: Small extracellular vesicles (sEVs) were isolated from Jurkat cells by size-exclusion chromatography and loaded with curcumin via sonication to generate JCsEV. Functional effects were assessed in vitro using wound healing, transwell invasion, and metabolic activity assays across multiple cancer cell lines. Therapeutic efficacy in vivo was evaluated in the 4-nitroquinoline 1-oxide (4-NQO) immunocompetent murine model of oral carcinogenesis. Female C57BL/6J mice received intraperitoneal treatment for four weeks with PBS, free curcumin, unloaded JsEV, or JCsEV. Tumor number, tumor burden, and body weight changes were assessed at the experimental endpoint. Results: In vitro, JCsEV significantly inhibited tumor cell migration, invasion, and metabolic activity compared with controls (p < 0.05). In vivo, treatment with JCsEV significantly reduced tumor number and tumor burden in the 4-NQO model (p < 0.01). In addition, body weight loss was reduced in JCsEV-treated mice compared with controls. Conclusion: sEV-mediated delivery of curcumin effectively suppresses tumor progression in experimental OSCC. These findings establish proof-of-concept for sEV-based nanomedicine as a therapeutic strategy for OSCC and provide a compelling rationale for further translational investigation of sEVs as drug delivery platforms. Full article
(This article belongs to the Special Issue Exosomes in Cancer Metastasis (2nd Edition))
Show Figures

Figure 1

18 pages, 555 KB  
Review
Hepatocellular Carcinoma in Southeast Asian Americans: Epidemiologic Trends, Screening Challenges, and Policy Implications
by Ahauve M. Orusa, Abby M. Lohr, Khalid F. Abu-Zeinah, Irene G. Sia, Jennifer L. Ridgeway, Aminah Jatoi and Nguyen H. Tran
Healthcare 2026, 14(10), 1314; https://doi.org/10.3390/healthcare14101314 - 12 May 2026
Viewed by 101
Abstract
Background: Southeast Asian Americans (SEAAs) experience a disproportionately high burden of hepatocellular carcinoma (HCC), with incidence in several subgroups (i.e., Cambodian, Laotian, and Vietnamese individuals) reaching up to nine times that of non-Hispanic Whites. HCC in SEAAs is largely driven by chronic hepatitis [...] Read more.
Background: Southeast Asian Americans (SEAAs) experience a disproportionately high burden of hepatocellular carcinoma (HCC), with incidence in several subgroups (i.e., Cambodian, Laotian, and Vietnamese individuals) reaching up to nine times that of non-Hispanic Whites. HCC in SEAAs is largely driven by chronic hepatitis B (HBV), hepatitis C (HCV), metabolic dysfunction–associated steatotic liver disease (MASLD), and alcohol-associated liver disease (ALD). Despite established screening guidelines, under-detection and delayed diagnosis remain common. Objective: To summarize epidemiologic patterns, risk factors, screening challenges, and potential interventions aimed at reducing HCC disparities among SEAAs. Design and Methods: This narrative review synthesized evidence from population based epidemiologic studies, community-based interventions, health services research, and policy analyses. Attention was given to studies reporting disaggregated SEAA subgroup data. Findings derived from SEAA specific studies were distinguished from evidence drawn from broader Asian American or general cirrhosis populations, with inferential steps explicitly noted where subgroup specific data were limited. Key Findings: HCC incidence varies widely across SEAA subgroups, with elevated HBV- and HCV-related HCC in Vietnamese, Cambodian, and Laotian communities, and increasing MASLD-related HCC including among lean individuals who fall outside many surveillance frameworks. Screening and surveillance remain suboptimal, with fewer than 30% of patients with cirrhosis receiving recommended semiannual HCC surveillance and even lower uptake among SEAAs. Barriers include low HBV/HCV screening rates, limited disease awareness, language barriers, underinsurance, provider knowledge gaps, and lack of automated EHR-based reminders. Structural challenges such as poverty, transportation barriers, and limited access to specialty care further delay diagnosis. Proposed Interventions: Culturally tailored outreach programs, bilingual navigators, and community-based screening initiatives have demonstrated improved HBV/HCV testing and linkage to care. AI-enabled EHR tools may enhance identification of high-risk patients, streamline follow-up, and increase surveillance adherence. Expanded use of non-invasive fibrosis assessment and recognition of MASLD-related risk in non-obese individuals may support earlier detection. Policy priorities include mandatory Asian subgroup data disaggregation, expanded insurance coverage, and strengthened community-level healthcare infrastructure. Conclusions: SEAAs face a substantial and preventable HCC burden. A coordinated approach combining culturally tailored community engagement, improved provider support systems, and policy reforms is essential to improving early detection and reducing HCC disparities in this diverse population. Full article
12 pages, 1307 KB  
Article
Racial/Ethnic Disparities in Neoplasm-Related Mortality and the Social Determinants of Health
by Yoshito Nishimura, Mariko Fujii, Nanami Sako, Quynh Thi Vu, Ko Harada, Hideharu Hagiya, Urshila Durani, Stephen M. Ansell, James R. Cerhan and Toshihiro Koyama
Cancers 2026, 18(10), 1572; https://doi.org/10.3390/cancers18101572 - 12 May 2026
Viewed by 251
Abstract
Background/Objectives: Racial/ethnic and regional disparities in neoplasm-related mortality remain a significant public health challenge. In this study, we aimed to evaluate long-term trends in county-level neoplasm-related mortality rates by race/ethnicity in the United States and examine associations with social determinants of health. [...] Read more.
Background/Objectives: Racial/ethnic and regional disparities in neoplasm-related mortality remain a significant public health challenge. In this study, we aimed to evaluate long-term trends in county-level neoplasm-related mortality rates by race/ethnicity in the United States and examine associations with social determinants of health. Methods: We conducted a cross-sectional ecological study using population-based data from the Global Burden of Disease Study, including individuals residing in 50 states of the United States and the District of Columbia from 2000 to 2019. We analyzed age-standardized neoplasm-related mortality rates by ethnicity/race. Joinpoint regression analysis was used to identify significant changes in mortality trends, summarized as average annual percentage change. County-level correlations between mortality and key social determinants of health were also assessed. Results: Neoplasm-related mortality rates declined across all racial/ethnic groups from 2000 to 2019; however, disparities persisted. The age-standardized neoplasm-related mortality rates per 100,000 population decreased in all racial/ethnic subgroups. The average annual percentage change ranged from −0.94% (Hispanic and non-Hispanic American Indian or Alaska Native) to −1.90% (Black). Sex-specific analyses revealed similar trends. Southeastern states experienced slower declines than Northeastern states did. County-level smoking and poverty rates were positively correlated, whereas the primary care physician-to-population ratio, excessive alcohol consumption rate, mammography screening rate, and median household income were inversely correlated with neoplasm-related mortality rate, varying by race/ethnicity. Conclusions: Targeted, community-specific interventions are required to reduce inequities in cancer outcomes. Full article
(This article belongs to the Section Cancer Epidemiology and Prevention)
Show Figures

Graphical abstract

23 pages, 848 KB  
Review
Precision-Oriented Reconstruction After Spinal Sarcoma Resection: Integrating Surgical Strategy, Biologic Risk, and Emerging Technologies
by Tanner Carcione, Bradley Callas, Jack Thiara, Walter N. Jungbauer, Jonathan Jeger and Edward Reece
Cancers 2026, 18(10), 1555; https://doi.org/10.3390/cancers18101555 - 11 May 2026
Viewed by 223
Abstract
Background/Objectives: Primary spinal sarcomas, encompassing both bone and soft tissue histotypes, demand individualized reconstruction due to heterogeneous tumor biology, anatomic complexity, and host environments compromised by radiation, systemic therapy, or prior surgery. This narrative review reframes post-resection spinal reconstruction through a precision-medicine [...] Read more.
Background/Objectives: Primary spinal sarcomas, encompassing both bone and soft tissue histotypes, demand individualized reconstruction due to heterogeneous tumor biology, anatomic complexity, and host environments compromised by radiation, systemic therapy, or prior surgery. This narrative review reframes post-resection spinal reconstruction through a precision-medicine lens. Methods: A structured literature review was performed using PubMed and Scopus, targeting articles published between 2000 and 2026. Searches encompassed spinal sarcoma reconstruction, radiation and fusion, biologic reconstruction, and emerging technologies. Results: Tumor grade, radiation exposure, and systemic therapy timing emerge as multiplicative determinants of reconstructive environment quality, with drug-class-specific perioperative effects warranting stratified management. Vascularized bone grafts achieve reliable fusion in compromised hosts where avascular constructs fail. A precision-oriented reconstructive ladder is proposed as a conceptual, hypothesis-generating framework to guide strategy selection. Hybrid PSI-VBG constructs may further expand reconstructive possibilities. The evidence base remains largely composed of small, retrospective series. Conclusions: Individualized strategies anchored in tumor biology and host environment are the cornerstone of durable spinal sarcoma reconstructions. The proposed framework requires prospective, multi-institutional validation. Standardized outcome definitions, prospective registries, and histotype-stratified analyses are needed to advance the field. Full article
16 pages, 1920 KB  
Article
Influence of Cation Chain Length and Anion Identity in Imidazolium-Based Ionic Liquids on Lignin Depolymerization via Acid Hydrolysis
by Diana Lucía Campa-Guevara, Nohra Violeta Gallardo-Rivas, Erick Orlando Merinos-Herrera, Fausto Antonio Balderas-Jaramillo, Erika Alarcón-Ruiz and Luis Daniel Ordóñez-Pacheco
Molecules 2026, 31(10), 1609; https://doi.org/10.3390/molecules31101609 - 11 May 2026
Viewed by 238
Abstract
In this work, the ability of a series of imidazolium-based ionic liquids (ILs) to depolymerize Kraft lignin through acid hydrolysis was evaluated. ILs featuring two-, four-, and six-carbon alkyl chains combined with [Cl], [BF4] and [CH3COOH [...] Read more.
In this work, the ability of a series of imidazolium-based ionic liquids (ILs) to depolymerize Kraft lignin through acid hydrolysis was evaluated. ILs featuring two-, four-, and six-carbon alkyl chains combined with [Cl], [BF4] and [CH3COOH] anions were studied to determine the influence of cation and anion structure. The twelve ILs were synthesized and characterized by FT-IR and 1H/13C NMR spectroscopy. Results indicate that both the anion and cation significantly affect depolymerization efficiency; specifically, longer alkyl chain lengths correlated with higher conversion percentages. Anion efficacy followed the order: [Cl] > [CH3COOH] > [BF4]. Furthermore, reaction temperature did not show a significant impact on conversion within the studied range. Spectroscopic data suggest that bond dissociation follows a Brønsted acid-catalyzed mechanism, evidenced by the reduction of phenolic components and guaiacyl/syringyl units in the recovered lignin samples. Full article
Show Figures

Figure 1

18 pages, 4883 KB  
Article
Predictors of Interbody Fusion and Adjacent Segment Disease Following Anterior Lumbar Interbody Fusion for Degenerative Pathologies
by Zach Pennington, Abdelrahman M. Hamouda, Stanley Dennison, Michael L. Martini, Derrick Obiri-Yeboah, Jana Khalifeh, Rawad Turko, Mohamed M. El-Gohary, Clare A. Fogelson, Michelle J. Clarke, William E. Krauss, Brett A. Freedman, Melvin D. Helgeson, Ahmad N. Nassr, Arjun S. Sebastian, Anthony L. Mikula and Benjamin D. Elder
J. Clin. Med. 2026, 15(10), 3636; https://doi.org/10.3390/jcm15103636 - 9 May 2026
Viewed by 163
Abstract
Background/Objectives: To identify predictors of successful fusion and adjacent segment disease (ASD) following ALIF. Methods: Records of patients undergoing one- or two-level ALIF were queried for baseline and postoperative radiographic data, demographics, operative notes, and implant characteristics. All had ≥1 year [...] Read more.
Background/Objectives: To identify predictors of successful fusion and adjacent segment disease (ASD) following ALIF. Methods: Records of patients undergoing one- or two-level ALIF were queried for baseline and postoperative radiographic data, demographics, operative notes, and implant characteristics. All had ≥1 year of follow-up with CT, and multivariable Cox regression was used to identify predictors of radiographic fusion through the interbody, ASD, and ASD requiring reoperation. Results: In total, 177 patients (median 59 yr; 52.5% male) were treated at 245 unique levels, of which 193 fused (81.3% with posterior fixation and 59.6% with standalone), 43 had ASD (17.6%), and 14 had ASD requiring reoperation (5.7%). Fusion was predicted by anterior cage placement (HR 0.94/mm; 95% CI [0.90, 0.98]; p = 0.003) and BMP use (HR 1.92; [1.15, 3.18]; p = 0.012). Radiographic ASD was predicted by older age (HR 1.08 per year; [1.03, 1.14]; p < 0.001), undergoing a revision [vs. index] fusion operation (HR 3.51; [1.44; 8.59]; p = 0.006), lower preoperative disc height (HR 0.83/mm; [0.74, 0.94]; p = 0.003), and preoperative facet vacuum phenomenon (HR 2.46; [1.18, 5.15]; p = 0.017). None of the extracted variables predicted reoperation for ASD. Conclusions: BMP use along with anterior cage placement and posterior fixation may improve the odds of fusion through the interbody following one- or two-level ALIF. Adjacent segment pathology is more common in patients with greater preoperative degenerative pathology (vacuum sign; more collapsed disc) and advanced age. Pelvic fixation did not improve fusion odds, but the data highlight the benefits of supplementary posterior fixation vs. standalone ALIF. Full article
(This article belongs to the Section Orthopedics)
Show Figures

Figure 1

43 pages, 2390 KB  
Review
Fluoroscopy-Guided Motion Management in Particle Therapy: Evolution, Challenges, and AI-Enabled Opportunities
by Feifei Li, Keith M. Furutani and Chris J. Beltran
Tomography 2026, 12(5), 66; https://doi.org/10.3390/tomography12050066 (registering DOI) - 9 May 2026
Viewed by 124
Abstract
The sharp dose gradients that underpin the dosimetric advantage of particle therapy over photon therapy can be undermined by the interplay effects due to intra-fraction motion in modern pencil beam scanning systems. Fluoroscopy-Guided Particle Therapy (FGPT) offers a promising path to improved motion [...] Read more.
The sharp dose gradients that underpin the dosimetric advantage of particle therapy over photon therapy can be undermined by the interplay effects due to intra-fraction motion in modern pencil beam scanning systems. Fluoroscopy-Guided Particle Therapy (FGPT) offers a promising path to improved motion management through real-time tracking of tumors or surrogate signals. The advent of flat-panel detector (FPD)-based technology has enabled tighter integration of fluoroscopy/fluorography into treatment units and accelerated clinical adoption and research, with commercial systems such as Hitachi’s Real-time Gated Particle Therapy (RGPT) now available. However, the need for implanted fiducial markers, with the associated invasiveness and risk of complications, limits the utility of RGPT to a few anatomic sites in selected patients. The full potential of FGPT, therefore, depends on reliable marker-less tumor tracking, which remains challenging because soft-tissue targets are obscured by overlapping anatomy along the X-ray path, leading to reduced reliability of traditional image-registration algorithms in the projection domain. Recent advances in deep learning and AI-driven image registration have renewed hope for overcoming these barriers, enabling real-time marker-less tracking for particle therapy. This review outlines the evolution of fluoroscopy technology from image intensifier (II) to FPD-based systems, summarizes historical and recent vendor-supported FGPT strategies, and surveys emerging AI-based algorithms in the literature. A general review of machine learning-based image registration is provided, challenges in generalizability and interpretability are highlighted, and potential paths toward reliable, clinically deployable FGPT are discussed. Full article
(This article belongs to the Special Issue Progress in the Use of Advanced Imaging for Radiation Oncology)
16 pages, 5741 KB  
Article
Hybrid Curriculum Learning for Data-Efficient Lung Nodule Detection with YOLOv11
by Yi Luo, Yike Guo, Hamed Hooshangnejad, Xue Feng, Quan Chen, Zongwei Zhou, Yaxi Chen, Yipeng Hu, Rui Zhang and Kai Ding
Diagnostics 2026, 16(10), 1441; https://doi.org/10.3390/diagnostics16101441 - 8 May 2026
Viewed by 230
Abstract
Background/Objectives: Accurate detection of pulmonary nodules on chest CT is critical for lung cancer screening, yet training robust detectors remains challenging due to the high cost of reliable annotations. In this work, we present a systematic study of curriculum learning for CT-based lung [...] Read more.
Background/Objectives: Accurate detection of pulmonary nodules on chest CT is critical for lung cancer screening, yet training robust detectors remains challenging due to the high cost of reliable annotations. In this work, we present a systematic study of curriculum learning for CT-based lung nodule detection on the enhanced LUNA25 benchmark and propose a hybrid curriculum learning framework for data-efficient optimization. Methods: Our approach estimates sample difficulty by fusing clinically interpretable handcrafted factors such as nodule size and count with model-driven signals such as prediction confidence from a teacher model, and constructs a three-stage progressive training curriculum from easy to hard samples. Using YOLOv11s as a strong baseline, the proposed hybrid curriculum is compared against conventional training without curriculum learning and against single-source curricula. Results: On the held-out LUNA25 test set, hybrid curriculum learning increases mAP50 from 0.672 to 0.696, mAP5095 from 0.369 to 0.385, recall from 0.588 to 0.634, and precision from 0.725 to 0.764. Extensive data-efficiency experiments with proportional reductions (1/2, 1/5, 1/10) and fixed training samples (5000–40,000 slices) further confirm consistent gains across limited-data regimes. Conclusions: These results demonstrate that jointly leveraging intrinsic image complexity and optimization-aware feedback provides effective sample scheduling for robust and data-efficient lung nodule detection. Full article
(This article belongs to the Special Issue Advances in Medical Image Processing)
Show Figures

Figure 1

17 pages, 636 KB  
Article
Placebo Response in Phase II-III Symptom Intervention Studies: A Focus on Chemotherapy-Induced Peripheral Neuropathy and Associated Neuropathic Pain
by David Zahrieh, Daniel Satele, Hiboombe Haamankuli, Xin Shelley Wang, Jennifer G. Le-Rademacher, Minji Lee, Heshan Liu, Julian Diaz-Cobo, Shu-En Shen, Selina Chow, Maryam Lustberg, Kathryn J. Ruddy and Ellen M. Lavoie Smith
Cancers 2026, 18(10), 1514; https://doi.org/10.3390/cancers18101514 - 8 May 2026
Viewed by 334
Abstract
Background/Objectives. Decades of research have failed to uncover effective approaches to prevent chemotherapy-induced peripheral neuropathy (CIPN), a common side effect of neurotoxic chemotherapy. Increased interest in placebo response as a potentially under-recognized confounder in CIPN trials was recently sparked by the results of [...] Read more.
Background/Objectives. Decades of research have failed to uncover effective approaches to prevent chemotherapy-induced peripheral neuropathy (CIPN), a common side effect of neurotoxic chemotherapy. Increased interest in placebo response as a potentially under-recognized confounder in CIPN trials was recently sparked by the results of a multisite NCI-funded phase II-III CIPN prevention study of duloxetine, a promising serotonin–norepinephrine reuptake inhibitor that enhances pain-inhibitory mechanisms within the central nervous system. Study findings revealed high and nearly equivalent response rates in three randomized treatment groups—little to no CIPN was reported by 65.2%, 66.0%, and 68.0% of study participants who received duloxetine 30 mg, 60 mg, or placebo treatment, respectively. Methods. We performed a meta-analysis of placebo response rates from seven randomized, double-blinded, placebo-controlled trials conducted over the past 20 years and comprising 191 placebo participants that were specifically testing interventions for oxaliplatin- and paclitaxel-induced peripheral neuropathy and that serially collected patient responses on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Chemotherapy-Induced Neuropathy questionnaire. Additionally, we sought to identify trial- and patient-specific factors that predicted higher placebo response rates from a participant-level pooled analysis. Results. The placebo response rate was 10.0% [95% CI: 5.8%, 16.6%] when response was defined more conservatively as patients reporting no neuropathy at all. When the placebo response was defined more broadly based on patients reporting no or a little neuropathy, the placebo response rate was higher (39.6% [95% CI: 27.4%, 53.2%]). Male participants, receipt of oxaliplatin, and a 2:1 randomization ratio favoring the intervention arm were individually associated with a higher placebo response. Conclusions. High placebo response rates can threaten scientific progress toward identifying effective treatments for cancer treatment-associated side effects, like CIPN. Careful attention to study design factors, participant eligibility, and patient and research staff expectations may help to minimize placebo response rates in future CIPN intervention studies. Full article
Show Figures

Figure 1

15 pages, 1635 KB  
Article
Machine Learning Models for Objective Assessment of Vascular Anastomoses Using Computational Fluid Dynamics for Surgical Skill Training—A Retrospective Study
by Levente Kiss-Pápai, Stefánia Reich, Júlia Varga, Wouter Oosterlinck, Peter Gloviczki and Balázs Gasz
J. Clin. Med. 2026, 15(10), 3588; https://doi.org/10.3390/jcm15103588 - 7 May 2026
Viewed by 283
Abstract
Background: Objective performance assessment is essential in surgical skill training, yet current methods are labor-intensive and focus on observing the trainee rather than the end-product of the procedure. Machine learning (ML) methods offer reproducible feedback but have mainly relied on kinematic or video [...] Read more.
Background: Objective performance assessment is essential in surgical skill training, yet current methods are labor-intensive and focus on observing the trainee rather than the end-product of the procedure. Machine learning (ML) methods offer reproducible feedback but have mainly relied on kinematic or video data, often reducing assessment to binary or ternary classification. Our objective was to compare ML regression models predicting expert-assigned scores of vascular anastomoses from computational fluid dynamics (CFD) features of the final product. Additionally, we aimed to assess biomechanical plausibility of predictions. Methods: A total of 146 participants performed 419 end-to-side anastomoses on case-specific three-dimensional (3D) printed simulators. Anastomoses were digitized via 3D scanning, ranked by experts, and characterized using CFD-derived hemodynamic features. These served as input for linear models (Ridge, Partial Least Squares), support vector machines, and tree-based ensembles (Random Forest, Extremely Randomized Trees, and Extreme Gradient Boosting [XGBoost]), evaluated using 10-fold nested cross-validation with genetic hyperparameter optimization. Results: Inter-rater reliability of expert indicated strong agreement (intraclass correlation coefficient ICC3k = 0.846). XGBoost achieved the lowest mean root mean squared error of 0.758 (95% bootstrap CI: 0.722–0.799) and a coefficient of determination (R2) of 0.673 (0.617–0.725), with the most stable performance across folds. Shapley additive explanations (SHAP) identified the wall shear stress gradient, transverse wall shear stress, and maximum pressure as the most influential features—variables associated with intimal hyperplasia and atherosclerotic remodeling. Conclusions: Tree-based ensemble methods, particularly XGBoost, effectively modeled biomechanical properties against expert scores. Combining CFD and ML can provide reproducible, mechanistically relevant feedback in vascular surgical skill training. Full article
(This article belongs to the Special Issue Machine Learning in Vascular Surgery)
Show Figures

Figure 1

7 pages, 429 KB  
Communication
Synthesis of (Z)-6-Heneicosen-11-one, a Possible Pheromone Component of the Hickory Tussock Moth, Lophocampa caryae
by Peter Mayo and Sumudu Deepa Abeysekera
Molbank 2026, 2026(3), M2171; https://doi.org/10.3390/M2171 - 6 May 2026
Viewed by 205
Abstract
The compound (Z)-6-heneicosen-11-one, a possible pheromone component of the hickory tussock moth, Lophocampa caryae, and a known pheromone component of the Douglas fir tussock moth, Orgyia pseudotsugata, was synthesized by a new four-step procedure with a 39% overall yield [...] Read more.
The compound (Z)-6-heneicosen-11-one, a possible pheromone component of the hickory tussock moth, Lophocampa caryae, and a known pheromone component of the Douglas fir tussock moth, Orgyia pseudotsugata, was synthesized by a new four-step procedure with a 39% overall yield and a six-step procedure incorporating a protecting group with a 28% overall yield. This new synthesis is comparable to other similar syntheses for this molecule in the literature. Full article
(This article belongs to the Section Organic Synthesis and Biosynthesis)
Show Figures

Figure 1

Back to TopTop